LESIONS OF THE HEMATOPOIETIC SYSTEM IN A PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND THE EFFECTIVENESS OF TREATMENT WITH MYCOPHENOLATE MOFETIL

The article presents a clinical case of the use of mycophenolate mofetil in a patient with high activity of systemic lupus erythematosus (SLE) and suppression of hematopoietic systems. The patient had all the characteristic signs of a severe course of SLE with the development of a complication - sev...

Full description

Saved in:
Bibliographic Details
Main Authors: I.A. Mormol, O.A. Borzykh, N.D. Gerasymenko, C. Esanu, L.P. Ozarchuk
Format: Article
Language:English
Published: Poltava State Medical University 2022-12-01
Series:Проблеми екології та медицини
Subjects:
Online Access:https://ecomed-journal.org/index.php/journal/article/view/257
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832549747264585728
author I.A. Mormol
O.A. Borzykh
N.D. Gerasymenko
C. Esanu
L.P. Ozarchuk
author_facet I.A. Mormol
O.A. Borzykh
N.D. Gerasymenko
C. Esanu
L.P. Ozarchuk
author_sort I.A. Mormol
collection DOAJ
description The article presents a clinical case of the use of mycophenolate mofetil in a patient with high activity of systemic lupus erythematosus (SLE) and suppression of hematopoietic systems. The patient had all the characteristic signs of a severe course of SLE with the development of a complication - severe anemia (frequent exacerbations of the main disease, a significant and constant decrease in the number of erythrocytes and the level of hemoglobin in the general blood test against the background of glucocorticosteroid therapy, the severity of clinical symptoms). Damage to the hematopoietic system is characteristic of such patients and prevailed in the clinical picture of the disease and became the direct reason for seeking medical help. The appointment of mycophenolate mofetil made it possible to reduce the activity of manifestations of the main disease, reduce the development of possible complications, and in the future achieve clinical and laboratory remission. The clinical feature of this case is the effective use of mycophenolate mofetil in a patient with high activity of the course of SLE and the constant occurrence of a severe complication - severe anemia, against the background of glucocorticoid therapy. Damage to the hematopoietic system in the patient prevailed in the clinical picture of the disease and became the direct reason for seeking medical help. According to the literature, the use of mycophenolate mofetil in patients gives a positive clinical result in the treatment of such patients: reducing the activity of the course of the main disease, preventing complications, extending the period of clinical and laboratory remission. This approach will improve the quality of life of patients with this group of diseases with the additional advantage of reducing the burden on health care due to the reduction in the frequency of hospitalizations of patients with severe SLE.
format Article
id doaj-art-c623f3f7cc21428e91979bd0687c9c2a
institution Kabale University
issn 2073-4662
2519-2302
language English
publishDate 2022-12-01
publisher Poltava State Medical University
record_format Article
series Проблеми екології та медицини
spelling doaj-art-c623f3f7cc21428e91979bd0687c9c2a2025-02-03T06:09:48ZengPoltava State Medical UniversityПроблеми екології та медицини2073-46622519-23022022-12-01265-671010.31718/mep.2022.26.5-6.02257LESIONS OF THE HEMATOPOIETIC SYSTEM IN A PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND THE EFFECTIVENESS OF TREATMENT WITH MYCOPHENOLATE MOFETILI.A. Mormol0O.A. Borzykh1N.D. Gerasymenko2C. Esanu3L.P. Ozarchuk4Poltava State Medical UniversityPoltava State Medical UniversityPoltava State Medical UniversityPoltava State Medical UniversityMunicipal institution "City clinical hospital # 1 of Poltava city council"The article presents a clinical case of the use of mycophenolate mofetil in a patient with high activity of systemic lupus erythematosus (SLE) and suppression of hematopoietic systems. The patient had all the characteristic signs of a severe course of SLE with the development of a complication - severe anemia (frequent exacerbations of the main disease, a significant and constant decrease in the number of erythrocytes and the level of hemoglobin in the general blood test against the background of glucocorticosteroid therapy, the severity of clinical symptoms). Damage to the hematopoietic system is characteristic of such patients and prevailed in the clinical picture of the disease and became the direct reason for seeking medical help. The appointment of mycophenolate mofetil made it possible to reduce the activity of manifestations of the main disease, reduce the development of possible complications, and in the future achieve clinical and laboratory remission. The clinical feature of this case is the effective use of mycophenolate mofetil in a patient with high activity of the course of SLE and the constant occurrence of a severe complication - severe anemia, against the background of glucocorticoid therapy. Damage to the hematopoietic system in the patient prevailed in the clinical picture of the disease and became the direct reason for seeking medical help. According to the literature, the use of mycophenolate mofetil in patients gives a positive clinical result in the treatment of such patients: reducing the activity of the course of the main disease, preventing complications, extending the period of clinical and laboratory remission. This approach will improve the quality of life of patients with this group of diseases with the additional advantage of reducing the burden on health care due to the reduction in the frequency of hospitalizations of patients with severe SLE.https://ecomed-journal.org/index.php/journal/article/view/257systemic lupus erythematosussevere courseanemiatreatmentmycophenolate mofetil
spellingShingle I.A. Mormol
O.A. Borzykh
N.D. Gerasymenko
C. Esanu
L.P. Ozarchuk
LESIONS OF THE HEMATOPOIETIC SYSTEM IN A PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND THE EFFECTIVENESS OF TREATMENT WITH MYCOPHENOLATE MOFETIL
Проблеми екології та медицини
systemic lupus erythematosus
severe course
anemia
treatment
mycophenolate mofetil
title LESIONS OF THE HEMATOPOIETIC SYSTEM IN A PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND THE EFFECTIVENESS OF TREATMENT WITH MYCOPHENOLATE MOFETIL
title_full LESIONS OF THE HEMATOPOIETIC SYSTEM IN A PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND THE EFFECTIVENESS OF TREATMENT WITH MYCOPHENOLATE MOFETIL
title_fullStr LESIONS OF THE HEMATOPOIETIC SYSTEM IN A PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND THE EFFECTIVENESS OF TREATMENT WITH MYCOPHENOLATE MOFETIL
title_full_unstemmed LESIONS OF THE HEMATOPOIETIC SYSTEM IN A PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND THE EFFECTIVENESS OF TREATMENT WITH MYCOPHENOLATE MOFETIL
title_short LESIONS OF THE HEMATOPOIETIC SYSTEM IN A PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND THE EFFECTIVENESS OF TREATMENT WITH MYCOPHENOLATE MOFETIL
title_sort lesions of the hematopoietic system in a patient with systemic lupus erythematosus and the effectiveness of treatment with mycophenolate mofetil
topic systemic lupus erythematosus
severe course
anemia
treatment
mycophenolate mofetil
url https://ecomed-journal.org/index.php/journal/article/view/257
work_keys_str_mv AT iamormol lesionsofthehematopoieticsysteminapatientwithsystemiclupuserythematosusandtheeffectivenessoftreatmentwithmycophenolatemofetil
AT oaborzykh lesionsofthehematopoieticsysteminapatientwithsystemiclupuserythematosusandtheeffectivenessoftreatmentwithmycophenolatemofetil
AT ndgerasymenko lesionsofthehematopoieticsysteminapatientwithsystemiclupuserythematosusandtheeffectivenessoftreatmentwithmycophenolatemofetil
AT cesanu lesionsofthehematopoieticsysteminapatientwithsystemiclupuserythematosusandtheeffectivenessoftreatmentwithmycophenolatemofetil
AT lpozarchuk lesionsofthehematopoieticsysteminapatientwithsystemiclupuserythematosusandtheeffectivenessoftreatmentwithmycophenolatemofetil